10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-024229`
Period End Date	20220331
Filing Date	20220505
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	f10q0322_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 44 Income Statement 22 Cash Flow Statement 46 Stockholders Equity 17

Balance Sheet 44 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`Cash`	$44.44M	USD	Point-in-time
Cash and cash equivalents	`Cash`	$44.93M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$167.47M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$175.72M	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$86.38K	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$65.45K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$5.06M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$11.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$225.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$223.30M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$28.29K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$28.29K	USD	Point-in-time
Total assets	`Assets`	$225.81M	USD	Point-in-time
Total assets	`Assets`	$223.33M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Commitments and Contingencies (See Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (See Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.74M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	29.40M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.74M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.67M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.19M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	29.40M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.87M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.41M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.41M	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 29,402,824 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$27.74K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 29,402,824 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$29.40K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$555.18M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$513.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-344.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-305.07M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$208.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$210.40M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$225.81M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$223.33M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$14.02M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.01M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.38M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.28M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$38.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$22.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-38.30M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-22.41M	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$329.95K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$419.97K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-52.79K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-15.02K	USD	1 Quarter
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-1.76M	USD	1 Quarter
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-177.16K	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$190.02K	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$-1.45M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.40	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.34	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.39M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	16.57M	shares	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-22.22M	USD	1 Quarter
Net loss	`ProfitLoss`	$-39.75M	USD	1 Quarter
Depreciation expense	`Depreciation`	$806.00	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$11.93M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$5.85M	USD	1 Quarter
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-15.02K	USD	1 Quarter
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-52.79K	USD	1 Quarter
Unrealized loss on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-177.16K	USD	1 Quarter
Unrealized loss on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-1.76M	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-19.25K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-20.92K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-6.24M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$87.50K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-263.68K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-522.35K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$870.90K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$379.60K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-19.43M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.09M	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$20.66M	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$25.92M	USD	1 Quarter
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$36.13M	USD	1 Quarter
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$15.89M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.03M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$15.47M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$29.58M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$64.80K	USD	1 Quarter
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$467.77K	USD	1 Quarter
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$-1.46M	USD	1 Quarter
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$-300.01K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.93M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$29.95M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.31M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$490.94K	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.80M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.93M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.80M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.93M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Interest	`InterestPaidNet`	-	USD	1 Quarter

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.93M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.85M	USD	1 Quarter
ATM offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$29.58M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$300.01K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$1.46M	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$467.77K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$64.80K	USD	1 Quarter
Net loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-22.22M	USD	1 Quarter
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.